Cargando…
[5]-Helistatins: Tubulin-Binding Helicenes with Antimitotic Activity
[Image: see text] Helicenes are high interest synthetic targets with unique conjugated helical structures that have found important technological applications. Despite this interest, helicenes have had limited impact in chemical biology. Herein, we disclose a first-in-class antimitotic helicene, hel...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9709948/ https://www.ncbi.nlm.nih.gov/pubmed/36465552 http://dx.doi.org/10.1021/jacsau.2c00435 |
_version_ | 1784841270794911744 |
---|---|
author | Rushworth, James L. Thawani, Aditya R. Fajardo-Ruiz, Elena Meiring, Joyce C. M. Heise, Constanze White, Andrew J. P. Akhmanova, Anna Brandt, Jochen R. Thorn-Seshold, Oliver Fuchter, Matthew J. |
author_facet | Rushworth, James L. Thawani, Aditya R. Fajardo-Ruiz, Elena Meiring, Joyce C. M. Heise, Constanze White, Andrew J. P. Akhmanova, Anna Brandt, Jochen R. Thorn-Seshold, Oliver Fuchter, Matthew J. |
author_sort | Rushworth, James L. |
collection | PubMed |
description | [Image: see text] Helicenes are high interest synthetic targets with unique conjugated helical structures that have found important technological applications. Despite this interest, helicenes have had limited impact in chemical biology. Herein, we disclose a first-in-class antimitotic helicene, helistatin 1 (HA-1), where the helicene scaffold acts as a structural mimic of colchicine, a known antimitotic drug. The synthesis proceeds via sequential Pd-catalyzed coupling reactions and a π-Lewis acid cycloisomerization mediated by PtCl(2). HA-1 was found to block microtubule polymerization in both cell-free and live cell assays. Not only does this demonstrate the feasibility of using helicenes as bioactive scaffolds against protein targets, but also suggests wider potential for the use of helicenes as isosteres of biaryls or cis-stilbenes—themselves common drug and natural product scaffolds. Overall, this study further supports future opportunities for helicenes for a range of chemical biological applications. |
format | Online Article Text |
id | pubmed-9709948 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | American Chemical Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-97099482022-12-01 [5]-Helistatins: Tubulin-Binding Helicenes with Antimitotic Activity Rushworth, James L. Thawani, Aditya R. Fajardo-Ruiz, Elena Meiring, Joyce C. M. Heise, Constanze White, Andrew J. P. Akhmanova, Anna Brandt, Jochen R. Thorn-Seshold, Oliver Fuchter, Matthew J. JACS Au [Image: see text] Helicenes are high interest synthetic targets with unique conjugated helical structures that have found important technological applications. Despite this interest, helicenes have had limited impact in chemical biology. Herein, we disclose a first-in-class antimitotic helicene, helistatin 1 (HA-1), where the helicene scaffold acts as a structural mimic of colchicine, a known antimitotic drug. The synthesis proceeds via sequential Pd-catalyzed coupling reactions and a π-Lewis acid cycloisomerization mediated by PtCl(2). HA-1 was found to block microtubule polymerization in both cell-free and live cell assays. Not only does this demonstrate the feasibility of using helicenes as bioactive scaffolds against protein targets, but also suggests wider potential for the use of helicenes as isosteres of biaryls or cis-stilbenes—themselves common drug and natural product scaffolds. Overall, this study further supports future opportunities for helicenes for a range of chemical biological applications. American Chemical Society 2022-10-19 /pmc/articles/PMC9709948/ /pubmed/36465552 http://dx.doi.org/10.1021/jacsau.2c00435 Text en © 2022 The Authors. Published by American Chemical Society https://creativecommons.org/licenses/by/4.0/Permits the broadest form of re-use including for commercial purposes, provided that author attribution and integrity are maintained (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Rushworth, James L. Thawani, Aditya R. Fajardo-Ruiz, Elena Meiring, Joyce C. M. Heise, Constanze White, Andrew J. P. Akhmanova, Anna Brandt, Jochen R. Thorn-Seshold, Oliver Fuchter, Matthew J. [5]-Helistatins: Tubulin-Binding Helicenes with Antimitotic Activity |
title | [5]-Helistatins:
Tubulin-Binding Helicenes with Antimitotic
Activity |
title_full | [5]-Helistatins:
Tubulin-Binding Helicenes with Antimitotic
Activity |
title_fullStr | [5]-Helistatins:
Tubulin-Binding Helicenes with Antimitotic
Activity |
title_full_unstemmed | [5]-Helistatins:
Tubulin-Binding Helicenes with Antimitotic
Activity |
title_short | [5]-Helistatins:
Tubulin-Binding Helicenes with Antimitotic
Activity |
title_sort | [5]-helistatins:
tubulin-binding helicenes with antimitotic
activity |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9709948/ https://www.ncbi.nlm.nih.gov/pubmed/36465552 http://dx.doi.org/10.1021/jacsau.2c00435 |
work_keys_str_mv | AT rushworthjamesl 5helistatinstubulinbindingheliceneswithantimitoticactivity AT thawaniadityar 5helistatinstubulinbindingheliceneswithantimitoticactivity AT fajardoruizelena 5helistatinstubulinbindingheliceneswithantimitoticactivity AT meiringjoycecm 5helistatinstubulinbindingheliceneswithantimitoticactivity AT heiseconstanze 5helistatinstubulinbindingheliceneswithantimitoticactivity AT whiteandrewjp 5helistatinstubulinbindingheliceneswithantimitoticactivity AT akhmanovaanna 5helistatinstubulinbindingheliceneswithantimitoticactivity AT brandtjochenr 5helistatinstubulinbindingheliceneswithantimitoticactivity AT thornsesholdoliver 5helistatinstubulinbindingheliceneswithantimitoticactivity AT fuchtermatthewj 5helistatinstubulinbindingheliceneswithantimitoticactivity |